ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
38 215,28
1,06%
DAX
17 932,17
-1,10%
Brent Oil
83,455
-2,84%
Bitcoin
58 590,49
-3,32%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Deciphera Pharmaceuticals Inc (DCPH)

  7. Deciphera Pharmaceuticals Inc (DCPH) Actualités

DCPH Deciphera Pharmaceuticals Inc

25,375
0,105 (0,42%)
Dernière mise à jour : 20:25:47
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Deciphera Pharmaceuticals Inc DCPH NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,105 0,42% 25,375 20:25:47
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
25,29 25,27 25,40 25,27
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202413:00BWDeciphera Pharmaceuticals to be Acquired by ONO..
09/4/202413:00BWDeciphera Pharmaceuticals to Present at the Stifel 2024..
27/2/202413:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
20/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202413:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/2/202413:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202413:10EDGAR2Form 8-K - Current report
06/2/202413:00BWDeciphera Pharmaceuticals Announces Fourth Quarter and Full..
01/2/202422:50BWDeciphera Pharmaceuticals to Announce Fourth Quarter and..
01/2/202413:00BWDeciphera Pharmaceuticals to Present at the Guggenheim..
18/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202417:13BWDeciphera Pharmaceuticals Presents Long-Term Follow-Up..
08/1/202413:14EDGAR2Form 8-K - Current report
08/1/202413:00BWDeciphera Pharmaceuticals Announces Planned 2024 Corporate..
05/1/202413:00BWDeciphera Pharmaceuticals Announces Nature Medicine..
02/1/202413:00BWDeciphera Pharmaceuticals to Present at the 42nd Annual J.P...
14/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202300:05EDGAR2Form 144 - Report of proposed sale of securities
29/11/202313:00BWDeciphera Pharmaceuticals to Present at the JMP Securities..
07/11/202313:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
31/10/202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202312:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202312:06EDGAR2Form 8-K - Current report
30/10/202312:01BWDeciphera Pharmaceuticals Announces Third Quarter 2023..
30/10/202312:00BWDeciphera Pharmaceuticals Announces Positive Top-line..
29/9/202315:00PRNUSMedison Pharma Announces Public Formulary Listing of..
19/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202323:00BWDeciphera Pharmaceuticals, Inc. Announces Inducement Grants..
05/9/202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/8/202322:05BWDeciphera Pharmaceuticals, Inc. Announces Inducement Grants..
09/8/202313:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202313:06EDGAR2Form 8-K - Current report
09/8/202313:00BWDeciphera Pharmaceuticals Announces Second Quarter 2023..
03/8/202322:20EDGAR2Form 8-K - Current report
03/8/202322:15BWDeciphera Pharmaceuticals Announces Retirement of Daniel L...
02/8/202313:00BWDeciphera Pharmaceuticals to Announce Second Quarter 2023..
25/5/202323:00BWDeciphera Pharmaceuticals to Present Data from INTRIGUE..
23/5/202313:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
08/5/202313:00BWDeciphera Pharmaceuticals to Present at the JMP Securities..

Dernières Valeurs Consultées

NASDAQ
DCPH
Deciphera Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés